Motif Neurotech, a company specialising in bioelectronics for mental health, has raised $18.75m in a series A funding round. The money will be used to advance clinical development of its DOT microstimulator, a device designed to treat treatment-resistant depression (TRD) by stimulating specific brain circuits. The funding will also help the company enhance the device, scale production and distribution.

The NCSC wants developers to get serious on software security
The NCSC’s new Software Security Code of Practice has been praised by cyber professionals as a significant advancement in enhancing software supply chain security.